Solid dosage forms from self-emulsifying lipidic formulations

Pharmaceutical Technology Europe

Volumn 20, Issue 4, 2008, Pages 46-49

  Marchaud, Delphine ^a   Hughes, Sophie ^a  

^a Gateffosse Pharmaceutical Products ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; CYCLOSPORIN A; EXCIPIENT; FAT DROPLET; FENOFIBRATE; IBUPROFEN; LIPIREX; PIROXICAM; RITONAVIR; SAQUINAVIR; SOLUFEN;

ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG METABOLISM; DRUG SOLUBILITY; DRUG STABILITY; DRUG UPTAKE; EMULSION; FIRST PASS EFFECT; HARD GELATIN CAPSULE; LIPOPHILICITY; SELF EMULSIFYING LIPIDIC FORMULATION; SOFT GELATIN CAPSULE; TABLET COMPRESSION; TABLET FORMULATION; TABLET HARDNESS;

EID: 47549084284     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. C.Y. Wu. et al., Pharmaceutical Research 22(1), 11-23 (2005).
2. C.J.H. Porter et al., Nature Reviews Drug Discovery 6(3), 231-248 (2007).